GPAS-Register-Now-EN

WFH GPAS: full program now available

We are pleased to announce that the full program for the WFH Global Policy and Access Summit (GPAS) is now available! Join us on October 27 and 28, 2022 to participate in discussions around strategies for sustaining and advancing bleeding disorders care in the fast-changing pandemic world, and strategies for sharing knowledge between national member organizations (NMOs), healthcare providers, and national governments.

Also available in: Français Español

The program includes plenary sessions where the spotlight is put on invited keynote speakers, educational sessions, lightning round sessions, and stakeholder discussions (by invitation only). To read the full program, click here.

One highlight from day two will be the educational session, “Tackling inequities in access—towards affordable care and treatment”, which will feature the following insightful presentations and notable speakers:

Brian O’Mahony, CEO, Irish Haemophilia Society, Dublin, Ireland

Bernadette Cappello, Technical Officer, Essential Medicines List Secretariat, World Health Organization, Geneva, Switzerland

Dejan Petrovic, President, Serbian Hemophilia Society, Belgrade, Serbia

Ekawat Suwantaroj, Lay Member, Board of Directors, World Federation of Hemophilia, Bangkok, Thailand

To find out more about the WFH Global Policy and Access Summit (GPAS), click here. To register today, click here.

The second edition of the WFH Global Policy and Access Summit (GPAS) is supported by funding from the Hemophilia Alliance and its member hemophilia treatment centres (HTCs) across the U.S.A.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.